Medicared For All Logo

Donna Mcnamara MD in Totowa, New Jersey

Home New Jersey Totowa

Donna Mcnamara MD has Hematology/oncology as her primary medical specialty. Their primary office is: 225 Minnisink Rd in Totowa, New Jersey. There is an additional office location, for a total of two, for Donna Mcnamara MD that can be viewed further down.

They're a part of the: Totowa Cancer Center medical group which has around 3 members. You can call their office at 862-657-4900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Loyola University Of Chicago, Stritch School Of Medicine and graduated in 1999 (around 25 years of experience). They are listed as doing telehealth appointments.


Donna M Mcnamara MD Office Phone and Directions

Donna Mcnamara MD
Totowa Cancer Center
225 Minnisink Rd
Totowa, New Jersey 07512
862-657-4900


Patient Ratings
Please rate your experience with Donna Mcnamara MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 862-657-4900


Enter a starting address:


Healthcare Info for Donna Mcnamara MD

Medical School: Loyola University Of Chicago, Stritch School Of Medicine
Graduation Year: 1999
The Primary Medical Specialty for Donna Mcnamara MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 3678508314
NPI #: 1376502237
NPI Created On: 03/20/2006
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RX0202X
License Number:
25MA07334600
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Humana
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Russian, Italian.


Services and Procedures include:

  1. Complete blood cell count (red cells, white blood cell, platelets), automated test
  2. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  3. New patient office or other outpatient visit, typically 60 minutes
  4. Established patient office or other outpatient, visit typically 25 minutes
  5. Established patient office or other outpatient, visit typically 40 minutes
  6. Initial hospital inpatient care, typically 70 minutes per day
  7. Subsequent hospital inpatient care, typically 25 minutes per day
  8. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
  9. Injection, pegfilgrastim, 6 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819111785

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 819158743

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803070733

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832182931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832182983

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832183035

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783552265

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813071591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813071595

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813071599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15


Additional Office Locations

1. Regional Cancer Care Associates Llc
92 2nd St
Hackensack, NJ 07601
Group Members: 111

Phone: 862-657-4900

Enter a starting address:


Hematology/oncology Professionals in Totowa

225 Minnisink Rd
Totowa, NJ
Totowa Cancer Center

225 Minnisink Rd
Totowa, NJ
Totowa Cancer Center

Providers in Totowa Cancer Center

1.Harry Harper

225 Minnisink Rd
Totowa Nj 07512-1804
Totowa Cancer Center
Hematology/oncology

2.Donna Mcnamara Md

225 Minnisink Rd
Totowa Nj 07512-1804
Totowa Cancer Center
Hematology/oncology

3.Elias Obeid Md

225 Minnisink Rd
Totowa Nj 07512-1804
Totowa Cancer Center
Hematology/oncology

View all 3 members of Totowa Cancer Center medical group